News Conference News PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis November 27, 2011
News Conference News RIBS III: Alternative DES Best Bet for DES In-Stent Restenosis November 22, 2011
News Conference News Paclitaxel-Eluting Bioabsorbable Stent Shows Advantage over Bare-Metal Version November 20, 2011
News Conference News Drug-Eluting Balloons an Option for Patients with BMS Restenosis, High Bleeding Risk November 17, 2011
News Conference News ‘Judicious Use’ of DES in Low-Risk Patients Could Save Over $200 Million per Year November 16, 2011
News Industry News REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES November 13, 2011
News Daily News DES Associated with Less Downstream Lesion Development than BMS L.A. McKeown November 04, 2011
News Industry News Elixir Medical Corporation Announces Successful Completion of First-In-Man Study Enrollment for Fully Bioresorbable Drug Eluting Coronary Scaffold System November 02, 2011
News Daily News DES Shows Slight Edge Over BMS in Patients with Kidney Disease L.A. McKeown October 21, 2011
News Daily News First DES for Above-the-Knee Vascular Disease on the Horizon L.A. McKeown October 18, 2011
News Industry News Boston Scientific Begins Clinical Trial Enrollment for OMEGA™ Platinum Chromium Stent System October 05, 2011
News Daily News Clinical Variables Added to Syntax Score Increases Predictive Ability L.A. McKeown September 30, 2011
News Daily News Model Tries to Simplify Choice Between Drug-Eluting, Bare-Metal Stents L.A. McKeown September 16, 2011
News Daily News Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES September 14, 2011
News Daily News Long-term Outcomes Similar for Biodegradable-Polymer, Permanent-Polymer DES September 12, 2011
News Daily News ISAR-CABG Published: DES Preferred for Saphenous Vein Graft Lesions Jason Kahn September 12, 2011
News Daily News Drug-Eluting Balloons Show ‘Impressive’ Results in Below-the-Knee Lesions Jason Kahn September 08, 2011
News Conference News Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS September 02, 2011
News Conference News Landmark Analyses Show Downside of Prolonged Antiplatelet Therapy September 02, 2011